Skip to content
★ Sign in to follow
SR

Stephen Rix

Executive
Control Bionics Limited
Insider activity · 24 months5 buys0 salesCumulative net flow
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€189k
▼ Sales (0 ops.)
—

Latest filing published 29 Oct 2026 for CONTROL BIONICS LIMITED, €32k.

Filing timeline

BuySale
Stephen Rix

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Stephen Rix: trading record in brief

Stephen Rix appears in our data through filings on Control Bionics Limited shares, published by ASX. In total, 5 filings cover trades dated from 21 July 2026 to 29 October 2026.

No open-market sale appears; the market trades are 5 purchases worth €189k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

In size, the median ticket on the buying side is €32k. Scaled by market value, the purchases weigh a median 0.18% of market cap (sample: 4 purchases). On 2 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 29 October 2026, the filings show an open-market purchase worth €32k in Control Bionics Limited. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from ASX disclosures alone and does not predict where the share price will go.

Companies and markets linked to Stephen Rix

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    DirectorExecutivesControl Bionics Limited
    50,250 AUD0ASX
    1,000,000 shares@ A$0.0502ShareASXASX:2924-03155566-2A1707107
    Canonical exit: 27 Jan 2027 (T+90)
  • ▲
    DirectorExecutivesControl Bionics Limited
    62,356 AUD23ASX
    1,044,087 shares@ A$0.05970.24% mcap18.0% of flowShareASXISIN AU0000114183ASX:2924-03149995-2A1704845
    Canonical exit: 17 Jan 2027 (T+90)
  • ▲
    DirectorExecutivesControl Bionics Limited
    10,406 AUD35ASX
    169,210 shares@ A$0.06150.035% mcap4.1% of flowShareASXASX:2924-03130181-2A1694210
    Canonical exit: 30 Nov 2026 (T+90)
  • ▲
    DirectorExecutivesControl Bionics Limited
    153,000 AUD39ASX
    2,040,000 shares@ A$0.0750.59% mcap49.8% of flowShareASXISIN AU0000114183ASX:2924-03120308-2A1689086
    Canonical exit: 10 Nov 2026 (T+90)
  • ▲
    DirectorExecutivesControl Bionics Limited
    30,000 AUD26ASX
    400,000 shares@ A$0.0750.12% mcap100.0% of flowShareASXISIN AU0000114183ASX:2924-03112768-2A1685272
    Canonical exit: 19 Oct 2026 (T+90)

5 of 5 declarations